Vanguard Report: The future of drug development – By Laura Piddock


18 Aug 2021

To celebrate its 50th anniversary, the British Society of for Antimicrobial Chemotherapy (BSAC) are inviting a select number of experts to share what they see as being the 21st-century solutions to one of the biggest and most complex challenges of our generation: antimicrobial resistance. In this post, GARDP Scientific Director Laura Piddock explores the challenges involved in re-stimulating the antimicrobial drug development market.

Read the viewpoint on the BSAC website here.


We use cookies to provide you a better experience and understand how our site is being used. To consent to the use of cookies, click ‘Accept’. Learn more about our cookie and privacy policy.